In Vitro Establishment of Tumorigenic Human B-Lymphoblastoid Cell Lines Transformed by Epstein-Barr Virus

DNA and Cell Biology

Volumn 22, Issue 11, 2003, Pages 727-735

  Takahashi, Tomoko ^a   Tahara, Hidetoshi ^d   Ide, Toshinori ^d   Furuichi, Yasuhiro ^b   Sugimoto, Masanobu ^b   Kawabe, Tamae ^b   Okazaki, Yuichi ^b   Itoh, Chie ^b   Noda, Keisuke ^b   Tajima, Manami ^b   Satoh, Misako ^b   Goto, Makoto ^c   Mitsui, Youji ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b GeneCare Research Institute   (Japan)

^c Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^d HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; PROTEIN P16; PROTEIN P53; SPHINGOLIPID ACTIVATOR PROTEIN 2; TELOMERASE;

AGAR MEDIUM; ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL IMMORTALIZATION; CELL LINE; CONTROLLED STUDY; DIPLOIDY; DOWN REGULATION; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; LYMPHOBLASTOID CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANEUPLOIDY; ANIMALS; B-LYMPHOCYTES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; DIPLOIDY; DOWN-REGULATION; GENES, P16; GENES, P53; GENES, RETINOBLASTOMA; GENES, TUMOR SUPPRESSOR; HERPESVIRUS 4, HUMAN; HUMANS; MICE; MICE, NUDE; MUTATION; PHENOTYPE; TELOMERASE;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 4; MUS MUSCULUS;

EID: 0344553256     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454903770946700     Document Type: Article

References (26)

1. CARNERO, A., HUDSON, J.D., PRICE, C.M., and BEACH, D.H. (2000). p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat. Cell Biol. 2, 148-55.
2. COUNTER, C.M., AVILION, A.A., LEFEUVRE, C.E., STEWART, N.G., GREIDER, C.W., HARLEY, D.B., and BACCHETTI, S. (1992). Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921-1929.
3. COUNTER, C.M., BOTELHO, F.M., WANG, P., HARLEY, C.B., and BACCHETTI, S. (1994). Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol. 68, 3410-3414.
4. DIEHL, V., KRAUSE, P., HELLRIEGEL, K.P., BUSCHE, M., SCHEDEL, I., and LASKEWITZ, E. (1977). Lymphoid cell lines: In vitro cell markers in correlation to tumorigenicity in nude mice. Haematol. Blood Transfus. 20, 289-296.
5. EPSTEIN, M.A. (2001). Historical background. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356, 413-420.
6. FRENSHNEY, R.I. (1987). Culture of Animal Cells. A Manual of Basic Technique. (Alan R. Liss, Inc., New York) pp. 140-144.
7. KATAOKA, H., TAHARA, H., WATANABE, T., SUGAWARA, M., IDE, T., GOTO, M., FURUICHI, Y., and SUGIMOTO, M. (1997). Immortalization of immunologically committed Epstein-Barr virus-transformed human B-lymphoblastoid cell lines accompanied by a strong telomerase activity. Differentiation 62, 203-211.
8. KAWA, K. (2000). Epstein-Barr virus-associated diseases in humans. Int. J. Hematol. 71, 108-117.
9. INK4A inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88.
10. INK4A and P15ink4b genes as a marker of disease in the follow-up of non-Hodgkin's lymphomas. Br. J. Haematol. 109, 97-103.
11. MILLER, G. (1990). Epstein-Barr virus biology, pathogenesis and medical aspects. In Virology. B.N. Fields and K.M. Knipe, eds. (Raven Press, New York) pp. 1921-1958.
12. NIEDOBITEK, G., MERU, N., and DELECLUSE, H.J. (2001). Epstein-Barr virus infection and human malignancies. Int. J. Exp. Pathol. 82, 149-170.
13. NILSSON, K. (1979). The Nature of Lymphoid Cell Lines and Their Relationship to the Virus (Springer-Verlag, Berlin).
14. NILSSON, K. (1992). Human B-lymphoid cell lines. Hum. Cell. 5, 25-41.
15. NILSSON, K., GIOVANELLA, B.C., STEHLIN, J.S., and KLEIN, G. (1977). Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int. J. Cancer 19, 337-344.
16. NOBLE, J.R., ROGAN, E.M., NEUMANN, A.A., MACLEAN, K., BRYAN, T.M., and REDDEL, R.R. (1996). Association of extended in vitro proliferative potential with loss of p16INK4 expression. Oncogene 13, 1259-1268.
17. OKUBO, M., TSURUKUBO, Y., HIGAKI, T., KAWABE, T., GOTO, M., MURASE, T., IDE, T., FURUICHI, Y., and SUGIMOTO, M. (2001). Clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Genet. Cytogenet. 129, 30-34.
18. QUELLE, D.E., ZINDY, F., ASHMUN, R.A., and SHERR, C.J. (1995). Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993-1000.
19. RINES, R.D., VAN ORSOUW, N.J., SIGALAS, I., LI, F.P., ENG, C., and VIJG, J. (1998). Comprehensive mutational scanning of the p53 coding region by two-dimensional gene scanning. Carcinogenesis 19, 979-984.
20. SATOH, M., YASUDA, T., HIGAKI, T., GOTO, M., TANUMA, S., IDE, T., FURUICHI, Y., and SUGIMOTO, M. (2003). Innate apoptosis of human B lymphoblasts transformed by Epstein-Barr virus: Modulation by cellular immortalization and senescence. Cell Struct. Funct. 28, 61-70.
21. SHIRATORI, M., SAKAMOTO, S., SUZUKI, N., TOKUTAKE, Y., KAWABE, Y., ENOMOTO, T., SUGIMOTO, M., GOTO, M., MATSUMOTO, T., and FURUICHI, Y. (1999). Detection by epitope-defined monoclonal antibodies of Werner DNA helicases in the nucleoplasm and their upregulation by cell transformation and immortalization. J. Cell Biol. 144, 1-9.
22. SUGIMOTO, M., IDE, T., GOTO, M., and FURUICHI, Y. (1999a). Incorrect use of "immortalization" for B-lymphoblastoid cell lines transformed by Epstein-Barr virus. J. Virol. 73, 9690-9691.
23. SUGIMOTO, M., IDE, T., GOTO, M., and FURUICHI, Y. (1999b). Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines. Mech. Ageing Dev. 107, 51-60.
24. TAHARA, H., TOKUTAKE, Y., MAEDA, S., KATAOKA, H., WATANABE, T., SATOH, M., MATSUMOTO, T., SUGAWARA, M., IDE, T., GOTO, M., et al. (1997). Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus. Oncogene 15, 1911-1920.
25. WALTER, J., MOLLER, P., MOLDENHAUER, G., SCHIRRMACHER, V., PAWLITA, M., and WOLF, J. (1992). Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice. Int. J. Cancer 50, 265-273.
26. WOLF, J., DRAUBE, A., BOHLEN, H., JOX, A., MUCKE, S., PAWLITA, M., MOLLER, P., and DIEHL, V. (1995). Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells. Int. J. Cancer 60, 527-533.